TEVA PHARMACEUTICAL INDUSTRIES LTD Total Assets

Quick Answer

TEVA PHARMACEUTICAL INDUSTRIES LTD reported Total Assets of $40.75 billion for the year ending 2025.

  • TEVA PHARMACEUTICAL INDUSTRIES LTD showed an increase of +3.6% in Total Assets from 2024 to 2025.
  • This data is from TEVA PHARMACEUTICAL INDUSTRIES LTD's annual report (Form 10-K), filed with the SEC on February 3, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (23 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2018: $69.18 billion | Q2 2018: $67.03 billion | Q3 2018: $65.06 billion | Q1 2019: $59.85 billion | Q2 2019: $59.42 billion | Q3 2019: $57.25 billion | Q1 2020: $55.33 billion | Q2 2020: $54.99 billion | Q3 2020: $49.74 billion | Q1 2021: $49.00 billion | Q2 2021: $49.20 billion | Q3 2021: $47.85 billion | Q1 2022: $47.06 billion | Q2 2023: $43.10 billion | Q3 2023: $42.10 billion | Q1 2024: $42.77 billion | Q2 2024: $41.34 billion | Q3 2024: $41.76 billion | Q1 2025: $38.42 billion | Q2 2025: $40.13 billion | Q3 2025: $39.86 billion.
  • Over the full 23 years of available data (2008 to 2025), TEVA PHARMACEUTICAL INDUSTRIES LTD's Total Assets has grown by 23.8%.
  • Historical annual values: Fiscal year 2025: $40.75 billion | Fiscal year 2024: $39.33 billion | Fiscal year 2023: $43.48 billion | Fiscal year 2023: $42.10 billion | Fiscal year 2023: $43.10 billion | Fiscal year 2023: $43.46 billion | Fiscal year 2022: $44.01 billion | Fiscal year 2022: $44.25 billion | Fiscal year 2022: $45.93 billion | Fiscal year 2021: $47.67 billion | Fiscal year 2020: $50.64 billion | Fiscal year 2019: $57.47 billion | Fiscal year 2018: $60.68 billion | Fiscal year 2017: $70.62 billion | Fiscal year 2016: $93.06 billion | Fiscal year 2015: $54.23 billion | Fiscal year 2014: $46.42 billion | Fiscal year 2013: $47.51 billion | Fiscal year 2012: $50.61 billion | Fiscal year 2011: $50.14 billion | Fiscal year 2010: $38.15 billion | Fiscal year 2009: $33.21 billion | Fiscal year 2008: $32.92 billion.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: